The 10th 3D Tissue Models Summit 2025 is partnered with:
Corning
Expertise Partner
Corning is a global, leading manufacturer of lab tools for growing cells, bioprocess manufacturing, liquid handling, benchtop equipment, among other solutions for life sciences. Corning strives to improve efficiencies and develop innovations that enable researchers to create breakthrough discoveries in areas like cancer, primary cells, stem cells, drug discovery, cell and gene therapy and lab automation.
ibidi
Exhibition Partner
ibidi is a leading supplier of functional cell-based assays and advanced products for cellular microscopy. It is our mission to develop, produce, and deliver innovative technologies that enable scientists to tackle the underlying mechanisms of major illnesses such as cancer, cardiovascular conditions, and autoimmune diseases. With our innovative research tools, we enable scientists to achieve outstanding success and breakthroughs in life sciences, pharma, biotechnology, and medical diagnostics. Our goal is to provide scientists with standardized workflows that result in reproducible and truly objective scientific data, which can also be translated into therapies.
LIDE
Exhibition Partner
LIDE is an award-winning oncology contract research organization with 14 years of delivering drug evaluation services to 200+ clients worldwide. We offer traditional preclinical CRO services like spheroid and organoid studies leveraging our 70+ CDX models and 2000 patient-derived xenograft (PDX) models. Our library covers 50+ cancer types and 200+ models harbor special naturally-occurred drug-resistant and/or interesting genetic alterations. Ask us about our proprietary 7-10 day in-vivo organoid validation assay.
Molecular Devices
Exhibition Partner
At Molecular Devices, we enable our customers to unravel the complexity of biological systems. We provide platforms for high-throughput screening, genomic and cellular analysis, colony selection, microplate detection, automated workflow solutions, as well as custom organoid services. These leading-edge products empower scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.
Physiogenex
Event Partner
Physiogenex is a preclinical CRO providing original and benchmarked models of obesity/type 2 diabetes and related co-morbidities: MASH, dyslipidemia, inflammation, diabetic nephropathy, HFpEF and atherosclerosis. For >20 years, we have been evaluating the efficacy of our clients’ drugs using gold standard experiments in our validated preclinical models. Our customers benefit from our experience in drug development and expertise in metabolic diseases, as demonstrated by our numerous co-publications with our industrial partners. Our expertise – your success.